CA2846347C - Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals - Google Patents
Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals Download PDFInfo
- Publication number
- CA2846347C CA2846347C CA2846347A CA2846347A CA2846347C CA 2846347 C CA2846347 C CA 2846347C CA 2846347 A CA2846347 A CA 2846347A CA 2846347 A CA2846347 A CA 2846347A CA 2846347 C CA2846347 C CA 2846347C
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- group
- chroman
- formula
- yloxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2011/065712 WO2013037388A1 (en) | 2011-09-12 | 2011-09-12 | Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2846347A1 CA2846347A1 (en) | 2013-03-21 |
| CA2846347C true CA2846347C (en) | 2019-05-21 |
Family
ID=44645708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2846347A Expired - Fee Related CA2846347C (en) | 2011-09-12 | 2011-09-12 | Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals |
Country Status (8)
| Country | Link |
|---|---|
| KR (1) | KR101817925B1 (ko) |
| AU (1) | AU2011376746B2 (ko) |
| CA (1) | CA2846347C (ko) |
| IL (1) | IL231096A (ko) |
| MA (1) | MA35814B1 (ko) |
| SG (1) | SG11201400518RA (ko) |
| WO (1) | WO2013037388A1 (ko) |
| ZA (1) | ZA201401335B (ko) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4168380A (en) | 1978-04-21 | 1979-09-18 | Hoffmann-La Roche Inc. | 7-Methoxy-5-oxo-5H-thiazolo[2,3-b]quinazoline-2-carboxylic acid |
| JPH0967336A (ja) | 1995-09-04 | 1997-03-11 | Kanebo Ltd | 新規なイソチオウレア誘導体 |
| ES2191284T3 (es) | 1997-03-27 | 2003-09-01 | Taisho Pharmaceutical Co Ltd | Derivados de 2-fenoxianilina. |
| BR0013899A (pt) | 1999-09-10 | 2003-07-08 | Merck & Co Inc | Composto, composição farmacêutica, processos de tratamento ou prevenção de câncer, de uma doença em que a angiogênese esteja implicada, da vascularização retinal, da retinopatia diabética, da degeneração macular relacionada a idade, de doenças inflamatórias, de uma doença ou condições dependentes da tirosina quinase, de patologias associadas com ossos, e, processos para produzir uma composição farmacêutica, e de reduzir ou prevenir dano tecidual em seguida a um evento isquêmico cerebral |
| WO2002032883A1 (fr) | 2000-10-18 | 2002-04-25 | Senju Pharmaceutical Co., Ltd. | Nouveau derive de 4-benzyloxyphenyle et utilisation de ce derive |
| FI20011507A0 (fi) | 2001-07-10 | 2001-07-10 | Orion Corp | Uusia yhdisteitä |
| AU2003244181A1 (en) | 2002-06-25 | 2004-01-06 | Yamanouchi Pharmaceutical Co., Ltd. | Phenoxypyridine derivative or salt thereof |
| FI20030030A0 (fi) | 2003-01-09 | 2003-01-09 | Orion Corp | Uusia yhdisteitä |
| JP5092111B2 (ja) | 2007-02-05 | 2012-12-05 | トーアエイヨー株式会社 | ブトキシアニリン誘導体 |
| EP2103939A1 (en) | 2008-03-20 | 2009-09-23 | sanofi-aventis | Fluorescence based assay to detect sodium/calcium exchanger (NCX) "reverse mode" modulating compounds |
| US8354454B2 (en) | 2008-10-01 | 2013-01-15 | Merck Sharp & Dohme Corp. | Prodrugs of oxazolidinone CETP inhibitors |
-
2011
- 2011-09-12 SG SG11201400518RA patent/SG11201400518RA/en unknown
- 2011-09-12 CA CA2846347A patent/CA2846347C/en not_active Expired - Fee Related
- 2011-09-12 AU AU2011376746A patent/AU2011376746B2/en not_active Ceased
- 2011-09-12 WO PCT/EP2011/065712 patent/WO2013037388A1/en active Application Filing
- 2011-09-12 KR KR1020147009758A patent/KR101817925B1/ko active IP Right Grant
-
2014
- 2014-02-21 ZA ZA2014/01335A patent/ZA201401335B/en unknown
- 2014-02-23 IL IL231096A patent/IL231096A/en active IP Right Grant
- 2014-03-12 MA MA36819A patent/MA35814B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2846347A1 (en) | 2013-03-21 |
| SG11201400518RA (en) | 2014-04-28 |
| WO2013037388A1 (en) | 2013-03-21 |
| MA35814B1 (fr) | 2014-12-01 |
| ZA201401335B (en) | 2015-08-26 |
| IL231096A (en) | 2017-07-31 |
| IL231096A0 (en) | 2014-03-31 |
| AU2011376746B2 (en) | 2017-06-15 |
| KR101817925B1 (ko) | 2018-01-12 |
| KR20140063807A (ko) | 2014-05-27 |
| AU2011376746A1 (en) | 2014-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20180148440A1 (en) | Substituted 2-(chroman-6-yloxyl)-thiazoles and their use as pharmaceuticals | |
| EP2755970B1 (en) | Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals | |
| AU2014224579B2 (en) | Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals | |
| CA2846347C (en) | Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals | |
| JP5941637B2 (ja) | 置換２−（クロマン−６−イルオキシ）−チアゾール及び医薬としてのその使用 | |
| OA16755A (en) | Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals. | |
| NZ622127B2 (en) | Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals | |
| CN102993195A (zh) | 取代的2-(色满-6-基氧基)噻唑及其作为药物的用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20160907 |
|
| MKLA | Lapsed |
Effective date: 20210913 |